The aim of the study is to determine the significance of ezrin in the development and progression of colorectal carcinoma by evaluating its expression and determining its relation with clinicopathological parameters including gender, age, tumor histopathological type, site, gross appearance, size, histological grade, tumor stage and lymph node status to provide the evidence for clinical prognosis. Here, EZR is linked to colorectal carcinoma.